Literature DB >> 9431899

Qualitative and semi-quantitative value of a modified 13C-urea breath test for identification of Helicobacter pylori infection.

V Ellenrieder1, B Glasbrenner, C Stoffels, S Weiler, G Bode, P Möller, G Adler.   

Abstract

OBJECTIVE: The 13C-urea breath test (13C-UBT) is the method of choice in evaluating the success of therapy for eradication of Helicobacter pylori infection. For reasons of cost efficiency and practicability, urea dose and measurement duration have been reduced and the DOB (delta over baseline) cutoff level with the highest predictive value determined. Further, the efficacy of the modified 13C-UBT as a semi-quantitative test method was evaluated by comparison with histologically determined bacterial infiltration.
METHODS: In a prospective study, a modified 13C-UBT with reduced urea dose (75 mg) and shortened measurement duration (30 min) was administered to 145 patients. The DOB cutoff with the highest predictive value was determined using relative operating characteristic analysis. Reference methods included histology, bacterial culture and the rapid urease test. The DOB value was compared with the histologically determined grade of bacterial infiltration and the correlation evaluated using the Spearman ranking method.
RESULTS: Reduction of the DOB cutoff level from 5.0 per thousand to 3.5 per thousand led to significant improvement in sensitivity (78.9% vs. 91.2%) and accuracy (88.6% vs. 90.2%) of the 13C-UBT. Only five of 57 infected patients were incorrectly reported as non-infected after modification of the DOB level. In two of three patients in whom histological findings were negative but the 13C-urease test positive, bacterial growth was observed at culture. The DOB level correlated significantly with histological grade of bacterial infection.
CONCLUSION: The modified 13C-UBT proved to be a sensitive, practicable and cost-effective method for detecting H. pylori infection and permits a semi-quantitative estimation of bacterial infiltration.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9431899     DOI: 10.1097/00042737-199711000-00011

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  13 in total

Review 1.  The 13C urea breath test in the diagnosis of Helicobacter pylori infection.

Authors:  V Savarino; S Vigneri; G Celle
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

2.  Quantitation of Helicobacter pylori in dental plaque samples by competitive polymerase chain reaction.

Authors:  Q Song; B Haller; D Ulrich; A Wichelhaus; G Adler; G Bode
Journal:  J Clin Pathol       Date:  2000-03       Impact factor: 3.411

3.  Quantifying gastric Helicobacter pylori infection: a comparison of quantitative culture, urease breath testing, and histology.

Authors:  Sanjeev Tummala; Sunil G Sheth; Jeffrey D Goldsmith; Atoussa Goldar-Najafi; Christopher K Murphy; Marcia S Osburne; Steven Mullin; Debra Buxton; David A Wagner; Ciarán P Kelly
Journal:  Dig Dis Sci       Date:  2007-01-12       Impact factor: 3.199

4.  Comparison of a monoclonal antigen stool test (Hp StAR) with the 13C-urea breath test in monitoring Helicobacter pylori eradication therapy.

Authors:  Francesco Perri; Michele Quitadamo; Rosalba Ricciardi; Ada Piepoli; Rosa Cotugno; Annamaria Gentile; Alberto Pilotto; Angelo Andriulli
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

5.  Point-of-care Helicobacter pylori testing: primary care technology update.

Authors:  Brian D Nicholson; Lucy M Abel; Philip J Turner; Christopher P Price; Carl Heneghan; Gail Hayward; Annette Plüddemann
Journal:  Br J Gen Pract       Date:  2017-12       Impact factor: 5.386

6.  Prevalence of Helicobacter pylori in the adolescent oral cavity: dependence on orthodontic therapy, oral flora and hygiene.

Authors:  Andrea Wichelhaus; Lorenz Brauchli; Qunsheng Song; Guido Adler; Günter Bode
Journal:  J Orofac Orthop       Date:  2011-07       Impact factor: 1.938

7.  Helicobacter pylori infection, intake of analgesics or anti-inflammatory medication, and personal factors in relation to dyspeptic symptoms in patients of a general practitioner.

Authors:  G Bode; H Brenner; G Adler; D Rothenbacher
Journal:  Br J Gen Pract       Date:  2000-08       Impact factor: 5.386

8.  Helicobacter pylori in the oral cavity: high prevalence and great DNA diversity.

Authors:  Q Song; A Spahr; R M Schmid; G Adler; G Bode
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

9.  Helicobacter pylori colonization and diarrhoeal illness: results of a population-based cross-sectional study in adults.

Authors:  G Bode; D Rothenbacher; H Brenner
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

10.  An optimized 13C-urea breath test for the diagnosis of H pylori infection.

Authors:  Germán Campuzano-Maya
Journal:  World J Gastroenterol       Date:  2007-11-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.